Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Sirolimus × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Sarcoma 2 Rhabdomyosarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Hematologic Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1 Pinealoma 1 PRETEXT I Hepatoblastoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Multi-centric Castleman's Disease 1 Melanoma 1 Medulloblastoma 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphadenopathy 1

Interventions

Specimen Handling 7 Biopsy 6 ruxolitinib 2 fludarabine 2 decitabine and cedazuridine drug combination 2 Azacitidine 2 venetoclax 1 veliparib 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fedratinib 1 axatilimab 1 Topotecan 1 Tacrolimus 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Methotrexate 1 Melphalan 1 Janus Kinase Inhibitors 1 Injections 1 Idarubicin 1 High-Energy Shock Waves 1 Granulocyte Colony-Stimulating Factor 1 Geritol 1 Edetic Acid 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡